Skip to main content
logo
Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
44.84
-4.65 (-9.40%)
Aug 28, 2026, 4:00 PM EDT - Market closed

COAG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
237.3787.9774.41
Short-Term Investments
220.0997.5113.92
Cash & Short-Term Investments
457.46185.4988.33
Cash Growth
-110.00%-
Other Receivables
1.822.631.58
Receivables
1.822.631.58
Prepaid Expenses
4.724.443.33
Total Current Assets
464192.5593.24
Property, Plant & Equipment
1.51.72.57
Other Long-Term Assets
2.290.530.48
Total Assets
467.78194.7896.28

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
6.235.733.16
Accrued Expenses
5.263.962.47
Current Portion of Leases
0.460.690.79
Other Current Liabilities
0.990.290.27
Total Current Liabilities
12.9410.686.69
Long-Term Leases
0.570.571.1
Other Long-Term Liabilities
--0.02
Total Liabilities
13.5111.257.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.010.130.13
Additional Paid-In Capital
685.714.922.91
Retained Earnings
-228.7-181.86-117.95
Comprehensive Income & Other
-2.750.18-0.37
Total Common Equity
454.27-176.64-115.27
Shareholders' Equity
454.27183.5388.47
Total Liabilities & Equity
467.78194.7896.28

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
1.031.271.89
Net Cash (Debt)
456.43184.2286.43
Net Cash Growth
-113.13%-
Net Cash Per Share
55.14194.7391.37
Filing Date Shares Outstanding
46.710.040.95
Total Common Shares Outstanding
46.710.040.95
Working Capital
451.05181.8786.55
Book Value Per Share
9.73-4107.79-121.85
Tangible Book Value
454.27-176.64-115.27
Tangible Book Value Per Share
9.73-4107.79-121.85
Machinery
1.391.251.23
Leasehold Improvements
0.080.080.08
SEC Filings: 10-K · 10-Q